Header Logo

Connection

CHRISTIE BALLANTYNE to Administration, Oral

Back to Details
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Administration, Oral.
CHRISTIE BALLANTYNE
Connection Strength
0.390
Administration, Oral
  1. Oral PCSK9 Inhibitors. Curr Atheroscler Rep. 2024 05; 26(5):147-152.
    View in: PubMed
    Score: 0.196
  2. Bempedoic Acid (ETC-1002): A Current Review. Cardiol Clin. 2018 May; 36(2):257-264.
    View in: PubMed
    Score: 0.128
  3. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study). Am J Cardiol. 2008 May 15; 101(10):1428-36.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.